In the present study, breast CSCs were isolated from MDA-MB-231 breast cancer cells using a serum-free suspension culture, which characterizes the differential expression of cluster of differentiation 44 (CD44) and CD24 on the CSC cell surface combined with the capacity of CSCs to generate novel tumors when injected into a congenetic animal model. The gene discussed is CD44; the disease is breast cancer.